T. Rowe Price Associates’s Surgery Partners SGRY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.7M | Buy |
|
|||||
|
2025
Q2 | $1.68M | Buy |
|
|||||
|
2025
Q1 | $1.69M | Buy |
|
|||||
|
2024
Q4 | $1.4M | Buy |
|
|||||
|
2024
Q3 | $1.96M | Sell |
|
|||||
|
2024
Q2 | $9.04M | Sell |
|
|||||
|
2024
Q1 | $30.7M | Sell |
|
|||||
|
2023
Q4 | $35.4M | Sell |
|
|||||
|
2023
Q3 | $45.5M | Buy |
|
|||||
|
2023
Q2 | $70M | Buy |
|
|||||
|
2023
Q1 | $32.2M | Buy |
|
|||||
|
2022
Q4 | $13.2M | Sell |
|
|||||
|
2022
Q3 | $15M | Sell |
|
|||||
|
2022
Q2 | $63.3M | Sell |
|
|||||
|
2022
Q1 | $147M | Sell |
|
|||||
|
2021
Q4 | $150M | Buy |
|
|||||
|
2021
Q3 | $107M | Sell |
|
|||||
|
2021
Q2 | $179M | Sell |
|
|||||
|
2021
Q1 | $121M | Buy |
|
|||||
|
2020
Q4 | $215K | Buy |
|